Humby Frances, Bombardieri Michele, Manzo Antonio, Kelly Stephen, Blades Mark C, Kirkham Bruce, Spencer Jo, Pitzalis Costantino
William Harvey Research Institute, Barts and the London School of Medicine, Charterhouse Square, London, United Kingdom.
PLoS Med. 2009 Jan 13;6(1):e1. doi: 10.1371/journal.pmed.0060001.
Follicular structures resembling germinal centres (GCs) that are characterized by follicular dendritic cell (FDC) networks have long been recognized in chronically inflamed tissues in autoimmune diseases, including the synovium of rheumatoid arthritis (RA). However, it is debated whether these ectopic structures promote autoimmunity and chronic inflammation driving the production of pathogenic autoantibodies. Anti-citrullinated protein/peptide antibodies (ACPA) are highly specific markers of RA, predict a poor prognosis, and have been suggested to be pathogenic. Therefore, the main study objectives were to determine whether ectopic lymphoid structures in RA synovium: (i) express activation-induced cytidine deaminase (AID), the enzyme required for somatic hypermutation and class-switch recombination (CSR) of Ig genes; (ii) support ongoing CSR and ACPA production; and (iii) remain functional in a RA/severe combined immunodeficiency (SCID) chimera model devoid of new immune cell influx into the synovium.
Using immunohistochemistry (IHC) and quantitative Taqman real-time PCR (QT-PCR) in synovial tissue from 55 patients with RA, we demonstrated that FDC+ structures invariably expressed AID with a distribution resembling secondary lymphoid organs. Further, AID+/CD21+ follicular structures were surrounded by ACPA+/CD138+ plasma cells, as demonstrated by immune reactivity to citrullinated fibrinogen. Moreover, we identified a novel subset of synovial AID+/CD20+ B cells outside GCs resembling interfollicular large B cells. In order to gain direct functional evidence that AID+ structures support CSR and in situ manufacturing of class-switched ACPA, 34 SCID mice were transplanted with RA synovium and humanely killed at 4 wk for harvesting of transplants and sera. Persistent expression of AID and Igamma-Cmu circular transcripts (identifying ongoing IgM-IgG class-switching) was observed in synovial grafts expressing FDCs/CD21L. Furthermore, synovial mRNA levels of AID were closely associated with circulating human IgG ACPA in mouse sera. Finally, the survival and proliferation of functional B cell niches was associated with persistent overexpression of genes regulating ectopic lymphoneogenesis.
Our demonstration that FDC+ follicular units invariably express AID and are surrounded by ACPA-producing plasma cells provides strong evidence that ectopic lymphoid structures in the RA synovium are functional and support autoantibody production. This concept is further confirmed by evidence of sustained AID expression, B cell proliferation, ongoing CSR, and production of human IgG ACPA from GC+ synovial tissue transplanted into SCID mice, independently of new B cell influx from the systemic circulation. These data identify AID as a potential therapeutic target in RA and suggest that survival of functional synovial B cell niches may profoundly influence chronic inflammation, autoimmunity, and response to B cell-depleting therapies.
长期以来,在包括类风湿关节炎(RA)滑膜在内的自身免疫性疾病的慢性炎症组织中,一直存在着以滤泡树突状细胞(FDC)网络为特征的类似生发中心(GC)的滤泡结构。然而,这些异位结构是否会促进自身免疫和慢性炎症从而驱动致病性自身抗体的产生仍存在争议。抗瓜氨酸化蛋白/肽抗体(ACPA)是RA的高度特异性标志物,可预测不良预后,并且被认为具有致病性。因此,主要研究目标是确定RA滑膜中的异位淋巴结构是否:(i)表达激活诱导的胞苷脱氨酶(AID),这是Ig基因体细胞超突变和类别转换重组(CSR)所需的酶;(ii)支持正在进行的CSR和ACPA产生;以及(iii)在没有新的免疫细胞流入滑膜的RA/严重联合免疫缺陷(SCID)嵌合体模型中保持功能。
我们使用免疫组织化学(IHC)和定量Taqman实时PCR(QT-PCR)对55例RA患者的滑膜组织进行检测,结果表明FDC+结构始终表达AID,其分布类似于二级淋巴器官。此外,AID+/CD21+滤泡结构被ACPA+/CD138+浆细胞包围,这通过对瓜氨酸化纤维蛋白原的免疫反应性得以证明。此外,我们在GC外鉴定出了一个新的滑膜AID+/CD20+ B细胞亚群,类似于滤泡间大B细胞。为了获得直接的功能证据,证明AID+结构支持CSR和类别转换的ACPA的原位产生,我们将34只SCID小鼠移植了RA滑膜,并在4周时人道处死以获取移植组织和血清。在表达FDCs/CD21L的滑膜移植物中观察到AID和Igamma-Cmu环状转录本的持续表达(确定正在进行的IgM-IgG类别转换)。此外,滑膜中AID的mRNA水平与小鼠血清中循环的人IgG ACPA密切相关。最后,功能性B细胞龛的存活和增殖与调节异位淋巴细胞生成的基因的持续过表达有关。
我们证明FDC+滤泡单元始终表达AID并被产生ACPA的浆细胞包围,这提供了强有力的证据,表明RA滑膜中的异位淋巴结构具有功能并支持自身抗体的产生。将GC+滑膜组织移植到SCID小鼠中后,持续的AID表达、B细胞增殖、正在进行的CSR以及人IgG ACPA的产生,且独立于来自全身循环的新B细胞流入,这些证据进一步证实了这一概念。这些数据确定AID是RA的潜在治疗靶点,并表明功能性滑膜B细胞龛的存活可能会深刻影响慢性炎症、自身免疫以及对B细胞耗竭疗法的反应。